These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1363503)

  • 1. Genetically Engineered Vaccines: Prospects for Oral Disease Prevention. Proceedings of a workshop. Bethesda, Maryland, November 6-8, 1991.
    Adv Exp Med Biol; 1992; 327():1-326. PubMed ID: 1363503
    [No Abstract]   [Full Text] [Related]  

  • 2. Vaccines, cells, and nucleic acids. Workshop on vaccines prepared in continuous mammalian cell lines and by recombinant systems. London, July 1989. Proceedings.
    J Med Virol; 1990 May; 31(1):1-66. PubMed ID: 2376724
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetically engineered herpesvirus vaccines. Accomplishments in pigs and prospects in humans.
    Kit S; Kit M
    Prog Med Virol; 1991; 38():128-66. PubMed ID: 1647043
    [No Abstract]   [Full Text] [Related]  

  • 4. Emergency deployment of genetically engineered veterinary vaccines in Europe.
    Ramezanpour B; de Foucauld J; Kortekaas J
    Vaccine; 2016 Jun; 34(30):3435-40. PubMed ID: 27208587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetically engineered vaccines.
    Hughes JA; Brazeau GA
    Am Pharm; 1995 Dec; NS35(12):9-10. PubMed ID: 8546075
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetically engineered vaccines: problems and promises.
    Brown F; Dougan G; Snary D
    Microbiol Sci; 1984 Aug; 1(5):123-7. PubMed ID: 6444113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Engerix-B, a new genetically engineered hepatitis B vaccine, approved by FDA.
    Oncology (Williston Park); 1989 Dec; 3(12):44. PubMed ID: 2534905
    [No Abstract]   [Full Text] [Related]  

  • 8. [The vaccinia virus as a vector for genetically engineered vaccines and the study of viral protein functions].
    Vopr Virusol; 1986; 31(4):509-12. PubMed ID: 3464128
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of genetic engineering in veterinary medicine with examples from epidemiology, diagnosis and drug production].
    Mayr A; Hübert P
    Tierarztl Prax; 1990 Apr; 18(2):99-108. PubMed ID: 2112273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineered vaccines: from overview to a specific application.
    Chang HR; Wanebo HJ
    R I Med; 1993 Nov; 76(11):571-3. PubMed ID: 8312636
    [No Abstract]   [Full Text] [Related]  

  • 11. Genetically engineered vaccines: an overview.
    Dertzbaugh MT
    Plasmid; 1998; 39(2):100-13. PubMed ID: 9514708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reproductive Genetic Testing: Impact upon Women. Proceedings of NIH Workshop. Bethesda, Maryland, November 21-23, 1991.
    Fetal Diagn Ther; 1993 Apr; 8 Suppl 1():1-246. PubMed ID: 8099793
    [No Abstract]   [Full Text] [Related]  

  • 13. Research towards global control and prevention of tuberculosis with an emphasis on vaccine development. A Fogarty International Center Workshop, Bethesda, Maryland, 3-5 November 1987. Proceedings.
    Rev Infect Dis; 1989; 11 Suppl 2():S335-490. PubMed ID: 2711097
    [No Abstract]   [Full Text] [Related]  

  • 14. Proceedings of the Workshop on Bone Marrow Transplantation. Bethesda, Maryland, November 12-13, 1984.
    J Natl Cancer Inst; 1986 Jun; 76(6):1265-335. PubMed ID: 3520067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current status and prospects of molecular biology and oral medicine].
    Chen Q; Fu J; Li B
    Zhonghua Kou Qiang Yi Xue Za Zhi; 1995 Mar; 30(2):120-2. PubMed ID: 7648919
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthetic gene technology for new vaccines].
    Mäkelä PH
    Duodecim; 1988; 104(22):1874-80. PubMed ID: 3065068
    [No Abstract]   [Full Text] [Related]  

  • 17. [Genetic engineering and trends in the research on new vaccines].
    Hofnung M
    C R Seances Soc Biol Fil; 1988; 182(2):141-57. PubMed ID: 2461790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland, April 17-19, 1989.
    NCI Monogr; 1990; (9):1-184. PubMed ID: 2188147
    [No Abstract]   [Full Text] [Related]  

  • 19. Zinc and Health: Current Status and Future Directions. Proceedings of a workshop. Bethesda, Maryland, USA. November 4-5, 1998.
    J Nutr; 2000 May; 130(5S Suppl):1341S-1519S. PubMed ID: 10847802
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of oral complications in cancer patients.
    Peterson DE
    Prev Med; 1994 Sep; 23(5):763-5. PubMed ID: 7845955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.